A subsequent comparative analysis of ARAP1-AS1 expression in the blood of cancer patients versus healthy donors revealed significant differences in esophageal squamous cell carcinoma (ESCC), glioblastoma multiforme (GBM), and kidney renal clear cell carcinoma (KIRC) (Fig. 7B). Here, ARAP1 is linked to glioblastoma.